Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
27.47
-0.31 (-1.12%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Denali Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Denali Therapeutics stock have an average target of 38.22, with a low estimate of 22 and a high estimate of 90. The average target predicts an increase of 39.13% from the current stock price of 27.47.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $22 $38.22 $32 $90
Change -19.91% +39.13% +16.49% +227.63%

Analyst Ratings

The average analyst rating for DNLI stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 555555
Buy 443333
Hold 111112
Sell 000000
Strong Sell 000000
Total 101099910

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
JP Morgan
JP Morgan
Buy
Maintains
$29$28
Buy Maintains $29$28 +1.93% Oct 11, 2024
Raymond James
Raymond James
Hold
Initiates
n/a
Hold Initiates n/a n/a Oct 10, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$35
Buy Reiterates $35 +27.41% Sep 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$90
Strong Buy Reiterates $90 +227.63% Sep 4, 2024
B of A Securities
B of A Securities
Strong Buy
Maintains
$25$29
Strong Buy Maintains $25$29 +5.57% Sep 4, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
21.42M
from 330.53M
Decreased by -93.52%
Revenue Next Year
59.25M
from 21.42M
Increased by 176.62%
EPS This Year
-2.58
from -1.06
EPS Next Year
-2.73
from -2.58
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
26.68M335.66M48.66M108.46M330.53M21.42M59.25M164.80M
Revenue Growth
-79.34%1,158.19%-85.50%122.90%204.74%-93.52%176.62%178.13%
EPS
-2.070.63-2.39-2.60-1.06-2.58-2.73-2.10
EPS Growth
--------
Forward PE
--------
No. Analysts -----171612
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 52.5M 164.3M 513.6M
Avg 21.4M 59.3M 164.8M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High
-84.1%
667.2%
766.9%
Avg
-93.5%
176.6%
178.1%
Low - - -

EPS Forecast

EPS 20242025202620272028
High -2.27 -2.35 -0.61
Avg -2.58 -2.73 -2.10
Low -2.70 -3.17 -2.96

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.